These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10780242)

  • 1. Subjective and behavioral effects of repeated d-amphetamine in humans.
    Wachtel SR; de Wit H
    Behav Pharmacol; 1999 May; 10(3):271-81. PubMed ID: 10780242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans.
    Strakowski SM; Sax KW
    Biol Psychiatry; 1998 Dec; 44(11):1171-7. PubMed ID: 9836021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans.
    Strakowski SM; Sax KW; Setters MJ; Keck PE
    Biol Psychiatry; 1996 Nov; 40(9):872-80. PubMed ID: 8896773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram enhances subjective effects of dextroamphetamine in humans.
    Sofuoglu M; Poling J; Waters A; Sewell A; Hill K; Kosten T
    Pharmacol Biochem Behav; 2008 Sep; 90(3):394-8. PubMed ID: 18474395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rewarding effects of physical activity predict sensitivity to the acute subjective effects of d-amphetamine in healthy volunteers.
    Pester MS; Kirkpatrick MG; Geary BA; Leventhal AM
    J Psychopharmacol; 2018 Mar; 32(3):302-308. PubMed ID: 29338486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.
    Grady TA; Broocks A; Canter SK; Pigott TA; Dubbert B; Hill JL; Murphy DL
    Psychiatry Res; 1996 Aug; 64(1):1-10. PubMed ID: 8888359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
    Stoops WW; Vansickel AR; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants.
    Hamidovic A; Dlugos A; Skol A; Palmer AA; de Wit H
    Exp Clin Psychopharmacol; 2009 Dec; 17(6):374-83. PubMed ID: 19968402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.
    Kirkpatrick MG; Goldenson NI; Kapadia N; Kahler CW; de Wit H; Swift RM; McGeary JE; Sussman S; Leventhal AM
    Psychopharmacology (Berl); 2016 Jan; 233(1):89-97. PubMed ID: 26429791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of setting on the subjective and behavioral effects of d-amphetamine in humans.
    Zacny JP; Bodker BK; de Wit H
    Addict Behav; 1992; 17(1):27-33. PubMed ID: 1595423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine.
    Hamidovic A; Childs E; Conrad M; King A; de Wit H
    Drug Alcohol Depend; 2010 Jun; 109(1-3):175-80. PubMed ID: 20176450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociated effects of amphetamine on arousal and cortical blood flow in humans.
    Kahn DA; Prohovnik I; Lucas LR; Sackeim HA
    Biol Psychiatry; 1989 Mar; 25(6):755-67. PubMed ID: 2647156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
    J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.
    Lile JA; Babalonis S; Emurian C; Martin CA; Wermeling DP; Kelly TH
    J Clin Pharmacol; 2011 Jun; 51(6):888-98. PubMed ID: 20671295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.